Form 4 for NBIX NEUROCRINE BIOSCIENCES INC
Accepted 2023-04-27 00:00:00 ET · period of report 2023-04-25 · accession 0001209191-23-025862 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-04-27 | 2023-04-25 | NBIX | Cooke Julie | CHRO | S - Sale | $103.82 | -100 | 27.6K | -0.4% | -$10.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-04-25 | S | D | 100 | $103.82 | 27,561 | D | — | — | (F2) Includes an aggregate of 237 shares purchased on February 28, 2023 from the Neurocrine Biosciences, Inc. 2018 Employee Stock Purchase Plan. |